FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

RELAXO Consensus Forecast

No. of reports in last year
7
No. of analysts
3
Average Consensus Forecast
632.43
Consensus Potential
-2.70%

RELAXO Price Target Potential

BrokerageTargetPotential
Sharekhan84526.59%
Karvy Stock Broking80923.32%
Dolat Capital6352.31%

RELAXO Targets in FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 62,100 for RELAXO
0% Bullish
100% Bearish
See buy or sell ideas on FrontPage Forums >>

RELAXO Ratings

Long term RELAXO rating by FrontPage users
4.4/5 (5 Ratings)

7 RELAXO share price target reports by brokerages below. See what is analyst's view on RELAXO share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. RELAXO Forum
  3. RELAXO Price Target

RELAXO Share Price Target

RELAXO Share Price Target - Broker Reports - 2020

3-Feb-20
Price @ Call: 725.62
Target: 845
BUY
Valuation – Maintain Buy with a revised PT of Rs. 845: We broadly maintain our estimates for FY2020, FY2021 and FY2022. The increase in customs duty on footwear will widen the price difference between imported and domestically manufactured footwear, which augurs well for footwear companies to gain in terms of volumes in the near term. Steady volume growth and consistent improvement in OPM will help Relaxo clock revenue and earnings CAGR of 17.1% and 30.3%, respectively, over FY2019-FY2022. The stock is currently trading at 59.8x its FY2021E earnings and 46.1x its FY2022E earnings. Given the company’s strong business prospects and better earnings visibility, we maintain our Buy recommendation on the stock with a revised PT of Rs. 845 (rolling it forward to FY2022 earnings).
... Read more
6-Feb-20
Price @ Call: 739.35
Target: 809
HOLD

RELAXO Share Price Target - Broker Reports - 2019

5-Nov-19
Price @ Call: 564.41
Target: 650
BUY
Valuation – We broadly maintain our estimates for FY2020 and FY2021 (we have also introduced FY2022 estimates) as Q2FY2020 performance was better than our expectation in a tough demand environment. The negative impact of Ind-AS 116 on PBT was limited to Rs. 2.1 crore. Capacity expansion will help boost volumes and add to revenue growth. Healthy volume growth and consistent improvement in OPM will help Relaxo clock revenue and earnings CAGR of 17% and 29%, respectively, over FY2019- FY2022. Given the company’s strong business prospects and better earnings visibility, we maintain our Buy recommendation on the stock with a revised PT of Rs. 650 (rolling it forward to average of FY2021 and FY2022 earnings).
... Read more
5-Nov-19
Price @ Call: 564.41
Target: 635
ACCUMULATE
We have revised our FY20E and FY21E estimates to factor in Q2 performance. We value the stock at 55x FY21E EPS to arrive at a TP of` 635.Considering rich valuations, downgrade to Accumulate. (Buy on Dips).
... Read more
7-Aug-19
Price @ Call: 435.31
Target: 508
BUY
We have broadly maintained our estimates for FY2020/ FY2021 as Q1FY2020 performance was largely in-line with expectation. The negative impact of Ind AS 116 on PAT in Q1 was around Rs. 2 crore. Roughly, we expect it to be around Rs. 8 crore for FY2020. We expect revenue and earnings to report a CAGR of 18% and 28%, respectively, over FY2019-FY2021. Proposed capacity expansion will help boost the volumes, thus, driving revenue growth. Given the company’s strong business prospects and better earning visibility, we maintain our Buy recommendation on the stock with a revised PT of Rs. 508 (valuing it at 44x FY2021E earnings).
... Read more
13-Aug-19
Price @ Call: 431.5
Target: 508
BUY
We have broadly maintained our estimates for FY2020/ FY2021 as Q1FY2020 performance was largely in-line with expectation. The negative impact of Ind AS 116 on PAT in Q1 was around Rs. 2 crore. Roughly, we expect it to be around Rs. 8 crore for FY2020. We expect revenue and earnings to report a CAGR of 18% and 28%, respectively, over FY2019-FY2021. Proposed capacity expansion will help boost the volumes, thus, driving revenue growth. Given the company’s strong business prospects and better earning visibility, we maintain our Buy recommendation on the stock with a revised PT of Rs. 508 (valuing it at 44x FY2021E earnings).
... Read more
9-Aug-19
Price @ Call: 430.96
Target: 472
HOLD
Despite the overall consumption decline particularly in the rural market, Relaxo seems to have managed to maintain good volume growth. We value the stock at 5 year average 1 year fwd P/E of 40x on FY21E EPS of Rs. 11.8. Key risks to the callare intensified competition from unorganized players, slower than expected pickupin demand and rise in raw material prices.
... Read more
29-May-19
Price @ Call: 417.45
Target: 443
HOLD
The stock trades at a one year forward P/E multiple of 43x. We believe the stock warrants premium valuation on the back of lower competition from major players in its space, strong reach, good fundamentals and good track record in penetration into the unorganized space in the smaller cities. We continue to value the stock at 38x on FY21E EPS of Rs. 23.4 and recommend ‘HOLD’. Key risks to the call areintensified competition from unorganized players, slower than expected pickup indemand and rise in raw material prices.
... Read more
14-May-19
Price @ Call: 397.28
Target: 484.5
BUY
Maintain Buy with a revised price target of Rs. 969: In view of the drop in OPM during FY2019, we have marginally reduced our earnings estimates for FY2019 and FY2020 by ~4.8% and ~1.4%, respectively. We believe that premiumisation of products, economies of scale and better cost efficiencies at the manufacturing maintain our Buy recommendation with a revised price target (PT) of Rs. 969.
... Read more
14-May-19
Price @ Call: 397.28
Target: 483.5
BUY
View: Double digit volume growth continues. Maintain Buy
Relaxo’s Q4FY19 results came in line with our estimates. For the eighth consecutive quarter, the company was able to report double digit volume growth. We have marginally tweaked our FY20E and FY21E earnings estimate at s 20.3 and Rs 24.2 respectively to factor in Q4 results. We continue to believe that the company would maintain its double digit revenue growth over our investment horizon. Valuing Relaxo at 40x FY21E to arrive at a TP of ` 967. Maintain Buy.
... Read more
8-Feb-19
Price @ Call: 371.28
Target: 430
BUY
8-Feb-19
Price @ Call: 365
Target: 455.5
BUY

RELAXO Share Price Target - Broker Reports - 2018

1-Oct-18
Price @ Call: 366.45
Target: 456.5
BUY
7-Aug-18
Price @ Call: 414.75
Target: 456.5
BUY
7-Aug-18
Price @ Call: 414.75
Target: 447
BUY
5-Feb-18
Price @ Call: 586.47
Target: 655
ACCUMULATE

RELAXO Share Price Target - Broker Reports - 2017

27-Sep-17
Price @ Call: 505.3
Target: 560
BUY
11-Aug-17
Price @ Call: 485.1
Target: 560
BUY
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • RELAXO Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3645.63
    Upside Target 2639.72
    Upside Target 1630.03
    Pivot624.12
    Downside Target 1614.43
    Downside Target 2608.52
    Downside Target 3598.83
  • RELAXO Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3704.7
    Upside Target 2689.85
    Upside Target 1662.7
    Pivot647.85
    Downside Target 1620.7
    Downside Target 2605.85
    Downside Target 3578.7
  • RELAXO Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3896.9
    Upside Target 2840.95
    Upside Target 1737.15
    Pivot681.2
    Downside Target 1577.4
    Downside Target 2521.45
    Downside Target 3417.65
  • RELAXO Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3639.72
    Upside Target 2633.76
    Upside Target 1630.08
    Pivot624.12
    Downside Target 1618.16
    Downside Target 2614.48
    Downside Target 3608.52
  • RELAXO Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3689.85
    Upside Target 2673.81
    Upside Target 1663.89
    Pivot647.85
    Downside Target 1631.81
    Downside Target 2621.89
    Downside Target 3605.85
  • RELAXO Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3840.95
    Upside Target 2779.93
    Upside Target 1742.22
    Pivot681.2
    Downside Target 1620.18
    Downside Target 2582.47
    Downside Target 3521.45
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020